APAnton PozniakMD, FRCPSlidesetHIVRussian HIV Clinical Forum 2018Optimal use of integrase inhibitors in routine clinical practice | Anton Pozniak, MD, FRCPView Slideset
SlidesetHIVRussian HIV Clinical Forum 2018Optimal use on integrase inhibitors in women and special populations (such as Injection drug users, HCV co-infected) | Elena Stepanova, MDView Slideset
JRJürgen RockstrohMDSlidesetHIVRussian HIV Clinical Forum 2018Two Drug Regimens - Pros and Cons | Jürgen Rockstroh, MDView Slideset
SlidesetHIVRussian HIV Clinical Forum 2018Clinical Case presentation | Elena Orlova-Morozova, PhDView Slideset
VideoHIVGlobal HIV Clinical Forum 2018One pill a day?: Integration novel delivery systems into routine care | Terry Blaschke, MDView Video
GvdBGuido van den BerkMD, PhDVideoHIVGlobal HIV Clinical Forum 2018Designing e-health interventions for HIV care | Guido van den Berk, MD, PhDView Video
VideoHIVGlobal HIV Clinical Forum 2018Clinical case: Integrase Inhibitors in Africa | Julia Turner, MDView Video
RZRebecca ZashMDVideoHIVGlobal HIV Clinical Forum 2018Implication of the resent Dolutegravir data | Rebecca Zash, MDView Video
DKDaniel KuritzkesMDVideoHIVGlobal HIV Clinical Forum 2018What is the Virological support for reduced drug regimens? | Daniel Kuritzkes, MDView Video
